{"result": "Here is a comprehensive summary of the data provided:\n\nPertuzumab is a humanized anti-HER2 monoclonal antibody that binds the HER2 receptor at a different epitope from trastuzumab. It is a medication used in cancer treatment, specifically in the treatment of HER2-positive breast cancer, including inflammatory breast cancer (IBC). Pertuzumab is also used to treat HER2+ breast cancer, especially in combination with trastuzumab, by blocking the HER2 protein. As a targeted therapy, it targets HER2 receptors and induces antibody-dependent cell-mediated cytotoxicity. Pertuzumab is a type of monoclonal antibody that binds to the HER2 receptor and is used in breast cancer treatment. It is often used in combination with other treatments, such as T-DM1, as part of a treatment regimen for HER2+ breast cancer. Additionally, pertuzumab has been used in clinical trials, including the NeoSphere clinical trial, and is a chemotherapy drug.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we the have full context.\n\n#######\n-Data-\nEntities: \"\\\"PERTUZUMAB\\\"\"\nDescription List: [\"\\\"Pertuzumab is a humanized anti-HER2 monoclonal antibody that binds the HER2 receptor at a different epitope from trastuzumab.\\\"\", \"\\\"Pertuzumab is a medication used in cancer treatment.\\\"\", \"\\\"Pertuzumab is a medication used in the treatment of HER2+ IBC.\\\"\", \"\\\"Pertuzumab is a medication used in the treatment of HER2-positive breast cancer.\\\"\", \"\\\"Pertuzumab is a medication used in the treatment of breast cancer.\\\"\", \"\\\"Pertuzumab is a medication used to treat HER2+ breast cancer, especially in combination with trastuzumab.\\\"\", \"\\\"Pertuzumab is a medication used to treat HER2-positive breast cancer by blocking the HER2 protein.\\\"\", \"\\\"Pertuzumab is a medication.\\\"\", \"\\\"Pertuzumab is a monoclonal antibody used in breast cancer treatment.\\\"\", \"\\\"Pertuzumab is a targeted therapy that targets HER2 receptors.\\\"\", \"\\\"Pertuzumab is a type of antibody that binds to the HER2 receptor and induces antibody-dependent cell-mediated cytotoxicity.\\\"\", \"\\\"pertuzumab is a HER2-targeting antibody.\\\"\", \"\\\"pertuzumab is a chemotherapy drug used in the NeoSphere clinical trial.\\\"\", \"\\\"pertuzumab is a chemotherapy drug.\\\"\", \"\\\"pertuzumab is a monoclonal antibody used in clinical trials.\\\"\", \"\\\"pertuzumab is a treatment regimen for HER2+ breast cancer, often used in combination with T-DM1.\\\"\", \"\\\"pertuzumab is a type of monoclonal antibody used to treat HER2+ breast cancer.\\\"\"]\n#######\nOutput:\n", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": null}}